Telesis Bio (TBIO) – FDA
-
Telesis Bio (TBIO) announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
-
Telesis Bio (TBIO) Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TBIO Stock Lookup